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Abstract
Background: Latest research demonstrates a significant improvement in stress-related symptoms in psychological
disorders as a result of exercise training (ET). Controlled clinical trials further validate the significance of ET by demonstrating
lower salivary cortisol levels in patients with post-traumatic stress disorder (PTSD) after intervention. A significant change in
cortisol and dehydroepiandrosterone (DHEA) levels can already be found after an 8–12-week ET program. The proposed
study aims to investigate the impact of an 8-week ET on PTSD symptoms and changes in cortisol levels in a juvenile
refugee sample from the Democratic Republic of the Congo (DRC) at an Ugandan refugee settlement. It is the first to
implement an ET intervention in a resource-poor, post-conflict setting.
Methods/design: In a randomized controlled trial, 198 adolescent participants aged 13–16 years from the DRC who, suffer
from PTSD, will be investigated. The participants are based at the Nakivale refugee settlement, an official refugee camp in
Uganda, Africa, which is among the largest in the world. The participants will be randomized into an Exercise Training (ET)
group with a maximum heart rate (HRmax) of > 60%, an Alternative Intervention (AI) group with low-level exercises, and a
Waiting-list Control (WC) group. After the 8-week interventional phase, changes in cortisol awakening response (CAR) and
DHEA in the ET group that correspond to an improvement in PTSD symptoms are expected that remain at follow-up after
3 months.
Discussion: To date, there is no controlled and reliable longitudinal study examining the effects of an ET program on
symptom severity in individuals with PTSD that can be explained with a harmonization of cortisol secretion. The presented
study design introduces an intervention that can be implemented with little expenditure. It aims to provide a promising
low-threshold and cost-effective treatment approach for the application in resource-poor settings.
Trial registration: German Trials Register, ID: DRKS00014280. Registered prospectively on 15 March 2018.
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Background
With more than 22.5 million refugees worldwide and
over 65 million people being forcibly displaced [1], the
provision of health services to these populations is
among the world’s most significant and challenging en-
deavors. These numbers are even more alarming when
one considers that nine of the top ten hosting countries
are not Western countries but mostly low- and
middle-income countries [1]. As most of these refugees
have had to flee from violent crises and have been ex-
posed to a number of stressful and traumatic experi-
ences, not only in their home countries but also during
their flight, millions of them suffer from trauma-related
mental health problems, in particular post-traumatic
stress disorder (PTSD) [2]. Generally, youth in conflict
zones are at risk of developing mental disorders related
to their exposure to continuous and traumatic stress,
which includes symptoms summarized under the diag-
nosis of PTSD [3]. Thus, the need for wide-scale,
trauma-focused interventions is massively important to
restoring refugees’ mental health. The resources that are
given, however, are often found to be very low [4] and
are particularly scarce for children and adolescents.
Therefore, effective steps are required to alleviate the
immense human and social costs [5]. Even if psycho-
therapeutic interventions would be capable of reducing
trauma-related suffering [6], most low- and middle-income
countries lack a substantial mental health system. More-
over, even if it has been proven that the training of lay
counselors and local health workers can be an effective
method [7], most professional psychotherapeutic interven-
tions are resource-demanding as they require the applica-
tion in one-to-one settings [8]. Besides a lack of resources,
stigmatization is another big issue for various countries
around the world and constitutes another barrier to mental
health services, thus contributing to social isolation,
distress, and difficulties in the lives of the affected people
[9]. The present research initiative, therefore, focuses on
Exercise Training (ET) as a promising way to administer
cost-effective and low-threshold group-intervention ap-
proaches. It will be administered in a refugee settlement in
Uganda, a low-income country that is currently the world’s
number-eight host country for refugees escaping violent
crises in neighboring countries, in particular the Demo-
cratic Republic of the Congo (DRC) [1].
The impact of Exercise Training (ET) on stress-related
mental health problems
Exercise Training (ET) has been shown to reduce an
individual’s perception of stress and to improve overall
mental health [10]. It is thereby important to demarcate
exercise from physical activity. Both activities can
involve large muscle groups that result in substantial
increases in heart rate and energy expenditure. The most
significant difference between the two is that exercise is
planned and structured while physical activity is not
[11]. Both can be distinguished as acute and chronic.
Acute exercise is the physiological response to a single
bout of exercise, while chronic exercise, which can also
be called exercise training, refers to the repeated per-
formance of acute exercise [11].
There are several studies describing chronic exercise as
a useful intervention for PTSD patients to reduce
trauma-related symptoms [12–14]. After implementing an
ET program, Fetzner and Asmundson [14] found signifi-
cantly reduced PTSD symptoms, with 88.9% of the partici-
pants reporting a clinically significant improvement.
Furthermore, previous research has shown significantly
higher reductions in PTSD, depression, anxiety, and
stress-symptom severity in PTSD patients who committed
to ET, compared to controls [12, 13]. According to a
meta-analysis of Rosenbaum et al. [15], who investigated
four intervention studies, a higher physical activity was re-
lated to less frequent and less-severe PTSD symptoms.
Two of these programs used combined aerobic exercises
[12, 13], whereas the other two used yoga sessions [16, 17]
in their program.
The glucocorticoid system as a potential target for the
beneficial effects of ET
Exercise is a very effective stimulator of the hypothalamic
-pituitary-adrenal (HPA) axis [18]. The hypothalamus pro-
duces the corticotropin-releasing hormone (CRH) which
stimulates the pituitary gland which in turn releases the
adrenocorticotropic hormone (ACTH) [19]. ACTH stimu-
lates the adrenal glands to release cortisol and dehydroepi-
androsterone (DHEA). DHEA and its sulfate form,
dehydroepiandrosterone sulfate (DHEAS), have been
found to possess anabolic properties [20], whereas high
cortisol has catabolic properties [21]. Furthermore,
DHEA/S has neuroprotective and anti-glucocorticoid ef-
fects [22]. Under normal conditions DHEA levels are
closely correlated with cortisol; however, an imbalance of
cortisol/DHEA secretion may occur when an individual
experiences chronic stress [23]. Cortisol and DHEA are
often addressed as a ratio that represents the balance
between anabolic and catabolic hormones [24]. Budde
et al. [25] found an increase in cortisol levels due to acute
exercise in adolescents. According to Hill et al. [26], the
exercise intensity necessary to provoke a significant in-
crease in circulation cortisol is 60% maximum rate of oxy-
gen consumption (VO2max), which shows an increase of +
39.9% in circulating cortisol levels. In general, untrained
participants had lower VO2max levels, significantly higher
responses to cortisol post exercise, and lower hair-cortisol
levels compared to participants who exercised regularly
[27–29]. In regard to the chronic effects of exercise, it
turned out that a higher training volume (measured in
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kilometers run per week) was associated with an increase
in cortisol levels in young healthy men [29]. After ET, a
decrease [30] as well as an increase [31] in cortisol levels
was found. A distinct rise in cortisol has been observed also
immediately after waking, typically peaking 30–45 min after
waking [32], and has been appropriately termed the cortisol
awakening response (CAR). This response is a neuroendo-
crine manifestation of the hypothalamic-pituitary-adrenal
axis (HPA-axis) has been demonstrated to be sensitive to
stressors like exercise. Although normative ranges have
been developed for several populations [33], it is still un-
clear what may constitute a “healthy” cortisol response, as
both elevated and depressed responses have been related to
dysfunctional psychosocial health status [34]. Compared to
adults, fewer data are available on hormone responses to
exercise in children and adolescents. Regarding the HPA re-
sponse to the physical activity status in adolescents,
cross-sectional findings revealed no significant changes
[35]. However, after presenting an acute exercise-related
stressor, young individuals at early stages of puberty showed
higher cortisol increases and lower DHEAS-to-cortisol
ratios than late pubertal participants [36].
The significance of glucocorticoids in PTSD
In various studies, alterations in the function of the
glucocorticoid system have also been reported for PTSD
patients. It is commonly accepted that PTSD patients
can have a dysfunction in the HPA-axis [37]. Results on
differences in baseline cortisol levels between individuals
with PTSD and controls are inconsistent, depending on
the research paradigm [38]. Several researchers found
reduced basal cortisol levels in PTSD patients compared
to healthy controls [39, 40]. In addition, cortisol levels
turned out to be a significant predictor for PTSD symp-
toms 6 weeks and 6 months after the traumatic event
[39]. At some time points, even higher cortisol levels
were found in participants who had PTSD [41].
Similarly, equivocal results exist surrounding the DHEA
response, in particular due to the smaller number of sys-
tematic studies in this field. Interestingly, there were
negative associations between hair-cortisol levels and the
number of different lifetime traumatic events, the frequency
of traumatization, and the time interval since
traumatization [40]. Regarding the cortisol levels of adoles-
cents and children with PTSD, research reports an increase
in cortisol concentration in PTSD victims [42]. Some other
studies did not find any significant differences in cortisol
levels in this age group [43] or even an attenuation in the
CAR [44].
Thus, even if cortisol and DHEA are associated with
PTSD and provide promising targets for the detection of
changes in HPA functioning, functional consequences
related to the development of stress-related psychopa-
thologies will have to be investigated in a subsequent
step, constituting a future research avenue. However, the
latest studies have demonstrated the usefulness of the
present research approach to utilize stress hormones as
an objective marker to validate the effectiveness of ET.
Kim and colleagues [45] showed a design that is com-
parable to the present study by demonstrating significant
changes in cortisol levels and also an improvement of
PTSD symptom severity after the adult participants
completed an 8-week ET program. In their study,
“Mindfulness-based Stretching” and “Deep Breath Exer-
cises” were used as low-intensity chronic exercise inter-
ventions. However, the intensity of ET had positive
effects on the improvement of PTSD symptoms [12–14].
Even if a few studies suggest ET to be beneficial for
children and adolescents with PTSD, no randomized
controlled trial (RCT) has been reported yet that directly
compares the effects of a cardiovascular condition to a
sham condition in a longitudinal design. To our know-
ledge, there is neither a study investigating the relation-
ship between a chronic exercise intervention and the
cortisol response in young PTSD victims, nor has it ever
been tested in a resource-poor, post-conflict setting.
Study aims
The purpose of this paper is to introduce a study protocol
for a RCT that aims to systematically investigate the im-
pact of ET on PTSD symptoms and associated cortisol
levels in adolescents. It is hypothesized that ET in adoles-
cents not only leads to a sustainable decrease in PTSD
symptoms in comparison to two control conditions (H1)
but that the changes in PTSD symptoms also correspond
to changes in cortisol (H2) and DHEA levels (H3) as
markers for beneficial alterations in HPA-axis functioning.
Furthermore, we expect differences in PTSD symptom se-
verity and cortisol/DHEA ratios between participants who
are highly physically active and those who are less physic-
ally active at baseline (t1) (H4).
Methods/design
Participants
This study investigates juvenile trauma victims from the
Democratic Republic of the Congo (DRC), aged 13–16
years, who are based at the Nakivale refugee settlement,
an official refugee camp in Uganda, Africa, which is
among the largest refugee camps in the world. The
government of Uganda and its United Nations High
Commissioner for Refugees (UNHCR) partners provide
general health services to the refugees in the settlement
with few psychotherapeutic interventions. Therefore,
Ainamani, Elbert, Olema, and Hecker [46] propose the
ample provision of trauma-focused treatment options
particularly in these settings in order to support not only
individual traumatized refugees but also their families
and the whole community. All participants will have a
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history of traumatic experiences. Participants eligible for
inclusion in the intervention only involve individuals
with a diagnosis of PTSD according to the Diagnostic
and Statistical Manual of Mental Disorders (DSM-V).
Exclusion criteria cover (1) acute suicidality, acute in-
toxication, or psychotic symptoms, (2) inability of the
parent or legal guardian to provide consent, or (3) child
protection issues (e.g., acute maltreatment) that are
identified during the initial cross-sectional assessment
and are judged by a clinician to make trial inclusion in-
appropriate. Additionally, the participants may not be
part of any other psychological therapy or take any
medication with psychoactive drugs until the study is
completed. We further control for an unchanged phys-
ical activity level during the intervention.
A prior sample size calculation was performed using
g*power 3 [47] based on (1) an expected medium effect
size in the overall model according to cortisol and PTSD
changes reported in previous studies [45], (2) the PTSD
symptom severity, the trauma load and the number of
potential stressors occurring during the intervention as
covariates, and (3) the number of time points. The de-
sired statistical power level was set at 0.95. The sample
size calculation was corrected for an estimated dropout
rate of 20%, according to other intervention studies that
have already been performed in the Nakivale refugee
settlement [48]. According to the power analysis, 159
participants are sufficient so that a total sample size of
198 participants is targeted to acknowledge potential
dropouts.
Study design
The present project, which was also registered at
www.drks.de before the start of data collection, contains
two subsequent steps: (1) a PTSD screening in a large
and representative sample of juvenile refugees from the
DRC that will serve to identify participants eligible for in-
clusion in the intervention. A cross-sectional analysis
comparing the physical activity levels of the refugees ac-
cording to their PTSD symptom severity will serve to
identify and balance potentially confounding variables.
With regard to cross-sectional studies, it is difficult to
make causal inferences because it is unknown if the par-
ameter itself (e.g., being cardiovascularly fit) caused the
benefit (e.g., reduced symptoms) or if other factors might
have accounted for the resultant differences [49]. There-
fore, (2) a longitudinal, prospective, and RCT will be im-
plemented covering the ET intervention and two control
conditions. Group (Exercise Training = ET, Alternative
Intervention =AI, and Waiting-list Control =WC) serves
as the between-subject factor. Eligible participants will be
randomly assigned to one of the three conditions. The
participants’ age, their traumatic load indicated by the
number of experienced traumatic event types, the baseline
PTSD symptom severity, and their physical activity level
will serve as matching criteria across groups. The study
utilizes a double-blind RCT design.
The ET group is subjected to an ET of 60–80% of the
maximal heart rate (HRmax). The AI group serves as the
placebo group and receives fine and gross motor body
coordination exercises through playful balance, bilateral
coordination, hand-eye coordination, and leg-arm coord-
ination exercises [49]. With such a sham-controlled
study, it will be examined whether the expected changes
in cortisol levels and symptom severity in PTSD patients
are attributed to chronic exercise and no other influen-
cing factors [50]. The WC group serves as a
no-treatment control and is measured at the same inter-
vals as the treatment group. It will not be implemented
until the ET and AI groups have finished their second
follow-up (t4). Introducing a second control group with
the alternative intervention is mandatory to differentiate
beneficial effects of miscellaneous physical activity from
standardized ET. This is not only important to investi-
gate a potential cross-cultural effectiveness of ET but
also serves to justify the specific training requirements
of ET and the need for sufficient resources in order to
build up sustainable intervention programs. The flow
diagram is presented in Fig. 1.
To assess the impact of chronic exercise on PTSD
symptoms and cortisol profiles, repeated measurements
with time (baseline (t1), interim test (t1b), post test (t2),
3-month follow-up (t3), and 6-month follow-up (t4)) as
the within-subject factor will be conducted on the pri-
mary outcome measures PTSD symptom severity and
awakening cortisol profiles. At eligibility (t0), the diagno-
sis will be verified and co-morbid diseases will be identi-
fied. In addition, at baseline (t1), the PTSD symptom
severity, relevant information about the participants’
trauma and flight history, as well as their exposure to
early life adversities will be assessed. As physiological
measures, cortisol and DHEA levels will be determined.
The assignment of participants to one of the three
groups will be conducted afterwards. An interim meas-
uring time point (t1b) at 4 weeks after the respective
intervention will serve to adjust the training to the indi-
vidual participant’s progress in the two exercise groups
in order to assure that the ET stays over 60% HRmax
after the 8-week interventional phase at the post test
(t2). The baseline measures will be repeatedly assessed at
the post test as well as the two follow-up measuring
points (t3 and t4; see Fig. 2 and Additional file 1).
Interventions
Exercise Training (ET) group
The participants in the ET group will attend three exer-
cise sessions every week for a total number of 8 weeks.
That makes this training a chronic exercise intervention
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[11]. Every unit takes 45 min. Two local and experienced
trainers from Uganda instruct identical classes of 25–35
participants. Each session will be performed with high
intensity with a HRmax of 70–85%. In our preliminary
work, significant cortisol and testosterone increases were
found by implementing an acute exercise of 70–85%
HRmax, but not with 50–65% HRmax [24]. The training
program will focus on improvement of cardiovascular
fitness through running and running-based games of
moderate to vigorous intensity (recorded on three oc-
casions by F1 Polar HR monitors; Polar, Kempele,
Finland) [49].
Alternative Intervention (AI) group
The aim of this group is to control the placebo effect by
implementing a training program in which lower
changes in cortisol and DHEA levels, and thereby a
lower improvement in PTSD symptoms compared to
the ET group, are expected. The participants will attend
three 45-min sessions a week for a total number of 8
weeks. The training of the AI group will consist of very
little strain, light stretching, and simple exercises that
target posture and balance [51] as well as fine and gross
motor body coordination through playful balance, bilateral
coordination, hand-eye coordination, and leg-arm coor-
dination exercises [49]. These sessions will also be con-
ducted in a group setting by local and experienced
trainers.
Waiting-list Control (WC) group
No specific intervention will be implemented. However,
the ET intervention will be done with this group after
the end of the measurement (t4).
Measures
Screening
The UCLA Child/Adolescent PTSD Reaction Index for
DSM-5 (UCLA; [52]) is a screening tool recommended
by the National Centre for PTSD to collect data about
the kind of traumatic happening the participants experi-
enced. It is a 24-item questionnaire assessed to DSM-V
criteria for PTSD.
The Mini International Neuropsychiatric Interview - Kid
7.0.2 (M.I.N.I.; [53]) represents a shortened psychiatric
interview on the basis of DSM-V in order to help
clinicians diagnose and evaluate the major psychiatric dis-
orders. The test takes about 15–20 min and is performed
in form of a standardized interview. The M.I.N.I. will help
Fig. 1 Participant flow diagram
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to identify acute co-morbid diseases relevant for eligibility
of the participants.
Primary outcome
For the more in-depth baseline PTSD assessment, the
Clinical Administered PTSD Scale for DSM-5 Child/
Adolescent Version (CAPS-CA-5; [54]) will be applied.
The CAPS-CA-5 is a 30-item structured interview for
the assessment of PTSD based on DSM-5 criteria. The
interview will take about 45–60 min and is considered
the gold standard for assessing PTSD severity. The
CAPS-CA-5 has excellent psychometric properties and
has already been successfully administered in other
East-African samples [55]. It will serve as the main
psychological outcome variable.
Secondary outcomes
The Adapted version of the Patient Health Questionnaire
(PHQ-A; [56]) for the use in adolescent samples will be
used as a measure to assess the participants’ depressive
symptomatology. It is a brief, nine-item measure that
assesses clinically significant symptoms of depressive dis-
orders and episodes in children ages 11–17 years.
The Strengths and Difficulties Questionnaire (SDQ; [57]) is
a brief behavioral screening questionnaire that can serve to
identify psychosocial, emotional, and behavioral problems. It
Fig. 2 Measures and assessment points used in the study
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is a widely used 25-item measure that has shown its useful-
ness in various studies and different populations with mental
health problems.
The Psychlops [58] is a client-generated outcome mea-
sure for the assessment of the main psychological problem
from the patients’ perspective. It is designed to measure
longitudinal changes over the course of an intervention
and provides different questions for the baseline, the in-
terim, and the follow-up assessments. In this study, it will
also help to capture the most significant mental health
problems beyond the diagnosis-specific approach.
Hormonal analysis
The determination of the cortisol awakening response
(CAR) will take place in following six samples:
1. Sample 1 “awakening” in the morning as soon as
the participants wake up
2. Sample 2 “post-awakening I” 30 min after taking the
awakening sample
3. Sample 3 “post-awakening II” 45 min after taking
the awakening sample.
4. Sample 4 “post-awakening III” 60 min after taking
the awakening sample
5. Sample 5 “post-awakening IV” at 9 a.m., collected
in the school
6. Sample 6 “post-awakening V” at 11 a.m., collected
in the school
Additionally, DHEA levels will be obtained at sample 1,
sample 2, and sample 3 only. The samples will be inde-
pendently collected in salivates by the participants. Saliva
will be collected by either passive drooling into the tube
or by chewing (for 2 min) the cotton provided with each
tube. Participants must wait at least 10 min after smoking,
consuming any food or drink, or teeth-brushing before
collecting the saliva sample. Previous research has found
different stimulation of salivary samples in children with
chronic malnutrition [59]. Therefore, our implemented
WC group provides the advantage of having a comparable
outcome among traumatized children without any treat-
ment condition. In addition, to control the possible influ-
ence of malnutrition onto hormonal samples, the Body
Mass Index (BMI) and the skinfold thickness will be deter-
mined. Tubes will be labeled with patient identifier and
returned to the laboratory via collection by the researcher.
Upon arrival at the laboratory, tubes with saliva will be
centrifuged to remove the upper salivary layer for subse-
quent measurement of cortisol and DHEA. The
DHEA-to-cortisol ratio will be determined by dividing
DHEA levels by the respective cortisol levels. The subjects
will be informed that the sample has to be collected ±
5 min according to the respective agreed time point. Free
cortisol levels in saliva will be measured using a
commercially available chemiluminescence assay (IBL,
Hamburg, Germany). The evaluation is carried out by C.
Kirschbaum in Dresden, Germany.
Physical performance measures
In the Shuttle Run Test the participants have to run al-
ternately between two lines that are 20 m separated from
each other. The running speed will be given by intervals
between tone signals. The interval between those signals
will be reduced at every level. At the beginning of the
test, the running speed is 8 km/h. Every minute it will
increase by 0.5 km/h. One minute is roughly equivalent
to one level of the shuttle run test. Every time the
acoustic hint sounds, the participants have to reach the
line. When a subject does not reach the line twice in a
row, the test will be over for them. The graduated
mileage will be noted and the appropriate VO2max level
can be read off [25].
The International Physical Activity Questionnaire -
Short Form (IPAQ-SF; [60]) captures the general physical
activity level of individuals by calculating the time of
moderate and vigorous physical activity as well as the
time that the participants spend walking and sitting. The
questionnaire had also been used in an African context
[61] and refers to the last 7 days.
The BMI will also be calculated by taking the body
weight in kilograms and dividing it by the height [62].
The total body fat will be determined by using a skin-
fold caliper.
A detailed list of all measuring instruments and the
times points at which they will be assessed is given in
Fig. 2.
Assessment
Due to the expected low experience with mental
health-related questions in the target populations, all
psychological instruments will be administered as
semi-structured clinical interviews held in Kiswahili. The
study and clinical interviews will be conducted by a team of
experienced master of science students (psychology) from
both Mbarara University and Bishop Stuart University in
southwestern Uganda. The research team will be exten-
sively trained in the concepts of mental disorders, data
collection, and interviewing techniques for a period of 3
weeks, both through in-person training and regular Skype
meetings. Additionally, trained, bilingual, English-speaking
local interpreters will be trained alongside experienced
clinical and counseling psychology students in clinical
interviewer skills to support the assessments. This proced-
ure has already been successfully used in other projects of
HA and RW and has proven its validity in various mental
health studies in East African samples. The team of inves-
tigators will also receive constant supervision by HA and
RW, both clinical psychologists/psychotherapists with
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extensive experience in the conduction of studies in
sub-Saharan post-conflict settings.
The psychological measures have already been success-
fully applied in other refugee samples in resource-poor set-
tings by HA and RW. The translation process for those
measures that have not yet been translated into Kiswahili
involves forward translations by two bilingual clinical
psychologists, synthesis, back translation by two different
experts, comparison and agreement on translation and
review, and modification by a team of local experts, local
assistants from the refugee community, and the principal
investigators (PIs). The procedure also involves a piloting
program involving juvenile DRC refugees to identify pro-
blematic phrases in the informed consent form, the instruc-
tions, and the items. This translation procedure is
commonly used in studies focusing on mental health issues
in similar samples and has proven its validity.
Initial procedure
This study will purposively select 198 refugee adolescents
using the quota sampling procedure that considers the
proportions of different sexes. Hence, the sample will con-
stitute 99 female and 99 male adolescent refugees each.
Every third household in each selected zone will be se-
lected as the target household until the desired number of
participants is reached. Before the interview, content, pro-
cedure, risks, the right to withdraw, and confidentiality
will be explained to each participant and written informed
consent (signature or fingerprints in case of illiteracy) will
be obtained. In addition to their parents, children, and ad-
olescents will also be asked to give their informed consent.
Potential participants as well as their legal authorized
representatives will be fully informed about the study
aims, the possible inconveniences of the clinical interview
procedures, the compensation for participation, and the
eligibility conditions of the treatment trial. After obtaining
informed consent, participants will be screened regarding
(1) their PTSD symptom severity, (2) potential exclusion
criteria, in particular suicidality and psychotic symptoms
according to the M.I.N.I., and (3) child protection issues
according to their reports in the trauma event list and
their clinical appearance during their contact with the
care-takers and the interviewers. Participants with notice-
able problems will receive a second check up by one of
the PIs and will receive referrals if action is required. The
screening will take about 60 min. Participants who are eli-
gible for inclusion in the treatment trial will attend a more
in-depth assessment that will take about 80 min. After-
wards, they will be randomly assigned to one of the three
interventions.
Statistical analysis
Over the course of the intervention, we will utilize a
repeated-measure, mixed-model approach in order to
identify significant changes in the main outcome vari-
ables between the three groups. Differences in baseline
PTSD symptom severity will be considered to acknow-
ledge nonlinear treatment effects between participants
with a different burden at t1. Potential confounding vari-
ables, such as the exposure to potentially traumatic
events during the course of the intervention, will be
used as covariates. All analyses will be performed using
R statistics and MPlus.
Methods to protect against sources of bias
All participants who were not excluded through allocation
will be randomized by a computer-generated program into
the ET, AI, and WC groups. Furthermore, the interviewers
do not know to which group the participants belong. All
participants are asked to not talk about their intervention
at any time point. The trainers are also blinded regarding
the hypotheses of the researchers and the intervention
under investigation. To acknowledge potential effects of
allegiance, trainers are not informed about expected diffe-
rences in the effectiveness of the interventions. Data ana-
lysts are blinded to group allocation. Blindness will be set
aside when a participant is (1) suicidal, (2) acutely in danger,
(3) overwhelmed by the intervention, (4) develops an add-
itional psychological disorder, (5) loses a massive amount of
weight, or (6) suffers under malnutrition. All names will be
pseudonymized and anonymized and can only be undone
by HB. Furthermore, 15% of the CAPS-CA-5 interviews are
reassessed by a second interviewer to establish inter-rater
reliability of the PTSD diagnosis and symptom severity.
Ethics approval and consent to participate
The Ethical Review Boards of the Medical School Hamburg
approved the study. Additionally, further permission will be
sought from the Uganda National Council for Science and
Technology. Informed consent will be sought from each
prospective participant and the participant’s legally autho-
rized representative. If any participant is likely to be suscep-
tible to undue influence or coercion, the investigators will
enforce additional safeguards in the study to protect such
participants. Additional referrals will be offered to patients
suffering from acute suicidality or other issues that require
acute treatment. As the provision of mental health services
in the refugee settlement is sparse we shall refer patients
with acute mental health problems to Mbarara Hospital Re-
ferral Department of Psychiatry for further treatment. Each
participant of the ET, AI, and WC groups will receive
20,000 Uganda shillings, equivalent to US$7, for compensa-
tion of their time and participation. In case of a significantly
positive treatment effect, additional ET will be offered to
participants from the AI and WC groups after completion
of the study to ensure access to a beneficial intervention.
Potential study participants and their parents must provide
written informed consent before they can be included in
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the study. Personal information about potential and en-
rolled participants will be collected and stored separately
from other study data and will be only accessible for the
assessors who contact the participants for data assess-
ment. The study dataset does not include personal infor-
mation and will be analyzed by the coordinating study
site. In case of an unexpected serious adverse event (e.g.,
life-threatening event, permanent damage, or death) over
the course of the study, the coordinating site will alert the
PI who will report the serious adverse event to the local
Ethics Committee. The Ethics Committee and the study
team will then decide in accordance with the best interest
of the patient if the study procedures are continued or
terminated.
Discussion
This study is designed to investigate the effects of an ET
program on the cortisol levels and symptoms of young
individuals with PTSD. There have been previous trials
examining the relationship between exercise and PTSD,
that have found significant improvements in symptom
severity through ET [12–14]. In regard to the relation-
ship between cortisol and PTSD, most studies confirmed
lower cortisol levels in PTSD patients [39, 40, 63], even
though in some cases higher cortisol levels were found
[38]. The relationship between cortisol and exercise in
healthy subjects, confirms changes through an imple-
mentation of an ET, but the response of cortisol varied
in those studies and depended on age [18, 30, 31, 35],
showing no different secretion due to the physical activ-
ity status for adolescent students [35]. The aim of the
described study is a combination of three factors: ET,
PTSD symptom severity, and cortisol/DHEA. There is
only one related study investigating this subject, using a
Mindfulness-based Stretching intervention in an adult
sample. Those researchers found significant changes in
cortisol levels and also an improvement in PTSD symp-
tom severity after the participants completed the 8-week
ET program. They confirmed that improved PTSD
scores were associated with a normalization of cortisol
levels [45]. It is unclear whether this intervention will be
intense enough for inducing cortisol changes in the
present younger population [25]. since a higher exercise
intensity is needed to induce changes in cortisol levels
after an ET program [26]. Taken together, PTSD patients
have a dysfunction in the HPA-axis [37] and we expect
the cortisol levels of PTSD patients to change by imple-
menting an ET program. Furthermore, we assume that
the change in cortisol levels will be associated with an
improvement of the PTSD symptoms.
The present study introduces an interventional pro-
gram that is easy to implement and, compared to most
psychological interventions, has the advantage of being
administered in groups. It is generally accepted that
group interventions that can be administered by laymen
are more cost-effective than therapeutic interventions in
a one-to-one setting that require extensive psychothera-
peutic expertise. However, besides face validity, the
cost-effectiveness of an ET intervention as proposed in
the present publication has not yet been evaluated in
terms of direct and indirect costs. Thus, the present
study provides further promising targets for interdiscip-
linary research on economic aspects of different poten-
tial health services in refugee settings.
Another advantage is that ET is not difficult to intro-
duce and no additional costly materials are needed. This is
in particular important for an ample provision of interven-
tions in resource-poor settings. Another benefit of the
present work lies in the recruitment of the participants in
the refugee settlement in Uganda, Africa, who are highly
affected by PTSD [64]. Previous research that strictly used
cross-sectional study designs offers a limited explanation
for the aim of the present work. Therefore, in addition to
a cross-sectional program, a longitudinal study design was
planned. This might provide the research field with more
meaningful and confirmatory results. In sum, there is no
study regarding the effect of an ET program on cortisol
levels and symptom severity in adolescent individuals with
PTSD. Therefore, the presented longitudinal RCT will
close this gap and will allow for a new promising approach
to overcome trauma-related suffering in PTSD-affected
refugee populations.
Trial status
TRLS-D-18-00245R, 18 June 2018, no recruitment yet.
Additional file
Additional file 1: Standard Protocol Items: Recommendations for
Intervention Trials (SPIRIT) 2013 Checklist: recommended items to address
in a clinical trial protocol and related documents. (PDF 71 kb)
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